SENISCA is seeking a Commercial and Partnerships Director to be in position by Summer 2022. This Executive level position will drive innovation, scientific excellence and commercial success. This exceptional opportunity is a leadership role, at the start of a high-growth journey for one of the UK’s leading RNA medicine biotech spinouts.

This new Director-level position will join the existing co-founders’ team of Chief Technical Officer, Chief Scientific Officer and launch Chief Executive Officer. It is intended that this role will be mainly based in Exeter UK, however there is potential for either a second UK-based SENISCA office, or a Europe or US-based satellite office or R&D base.

Core responsibilities include, but are not limited to:

• A lead role in the execution of strategic plans to develop and commercialise SENISCA’s pipeline therapeutic programmes, from discovery through to lead candidate and  clinical development.
• Develop relationships with external partners (including CRO’s and Pharmaceutical co-development partners) to leverage resources to advance pipeline, secure co-development partnerships and progress global in/out licensing deals.

Experience and skillsets to include:

• Expertise (scientifically or commercially) in an area of oligonucleotide therapeutics or senotherapies, or within any of the broad range of age-related disease(s) targeted by SENISCA’s platform technology.
• Track record of achievement in driving biotech programmes or initiatives to milestones.
• IP strategy setting experience and/or pharmaceutical sector global licensing experience.
• A willingness to carry out broad and diverse workflow responsibilities to support high growth and rapid team expansion.
• A work ethic, sense of urgency, adaptability and enthusiasm that will allow the successful candidate to thrive in a fast-paced, cutting-edge research environment.
• Excellent interpersonal and presentation skills.
• Strong influencing and negotiating skills.

Please send CV’s and initial enquiries to HR@senisca.com addressed to Anna Bennett (SENISCA’s Business Co-ordinator), within the initial application window of the 15th February to 15th of March 2022.